Covidien (NYSE: COV) announces the integration of its Nellcor™ BIS™ X4 brain monitoring software into the Mindray BeneView Series of multi-parameter patient monitors. BIS X4 technology monitors both hemispheres of a patient’s brain simultaneously and in real time, providing highly sophisticated data to help physicians make optimal decisions for safe patient care.
Covidien’s BIS technology provides a direct, real-time measure of the effects of anesthetics and sedatives on the brain. The goal for anesthesiologists is to use the minimal amount of anesthetic needed during a procedure to maintain patient sedation and prevent recall. Too little anesthesia can lead to patient awareness during surgery; too much can result in life-threatening respiratory depression.
The critical improvement offered by BIS X4 technology— the latest advancement to BIS — is that clinicians can compare activity between hemispheres of the brain, identify imbalances and intervene to achieve the best and safest patient outcomes. Studies indicate that BIS-monitored patients wake up faster, are extubated sooner, are better oriented upon arrival to the post anesthesia care unit (PACU) and are eligible for PACU discharge sooner.1, 2 Additionally, BIS technology may help clinicians measure anesthesia levels more precisely, which may decrease costs for surgical procedures3, 4 and ICU care.5, 6, 7 Incorporating BIS X4 technology in BeneView Series units enables physicians to adapt treatment to meet the specific needs of their patients, while also managing resource consumption effectively.
The incorporation of BIS X4 technology into its top-of-the-line multi-parameter BeneView Series patient monitors means that, for the first time, physicians globally can integrate critical data on patients’ brain activity with other vital sign information before, during and after anesthesiology and surgery. With the use of BIS X4-enhanced BeneView Series monitors, clinicians can tailor anesthesia delivery more accurately, which can improve patient outcomes, minimize serious complications and reduce healthcare costs.
For more information, visit www.covidien.com